A detailed history of Eldred Rock Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eldred Rock Partners, LLC holds 102,458 shares of MRK stock, worth $10.4 Million. This represents 3.91% of its overall portfolio holdings.

Number of Shares
102,458
Previous 98,465 4.06%
Holding current value
$10.4 Million
Previous $12.2 Billion 3.91%
% of portfolio
3.91%
Previous 5.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$111.15 - $128.97 $443,821 - $514,977
3,993 Added 4.06%
102,458 $11.7 Billion
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $492,476 - $528,914
3,978 Added 4.21%
98,465 $12.2 Billion
Q1 2024

Apr 11, 2024

BUY
$113.24 - $131.95 $106,445 - $124,032
940 Added 1.0%
94,487 $12.5 Billion
Q4 2023

Jan 11, 2024

BUY
$100.18 - $109.02 $9.37 Million - $10.2 Million
93,547 New
93,547 $10.2 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Eldred Rock Partners, LLC Portfolio

Follow Eldred Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldred Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eldred Rock Partners, LLC with notifications on news.